ReNAgade Therapeutics CEO Amit Munshi (L) and Orna Therapeutics CEO Tom Barnes

Re­NA­gade is ac­quired by RNA ri­val a year af­ter megaround-backed launch

Two buzzy, well-fund­ed biotech star­tups are com­bin­ing in a bid to cre­ate a pow­er­house at the bleed­ing edge of ge­net­ic med­i­cines.
Or­na Ther­a­peu­tics an­nounced Thurs­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.